[go: up one dir, main page]

FI893115A0 - Analogiamenetelmä terapeuttisesti käyttökelpoisten mitomysiinifosfaattijohdannaisten valmistamiseksi - Google Patents

Analogiamenetelmä terapeuttisesti käyttökelpoisten mitomysiinifosfaattijohdannaisten valmistamiseksi

Info

Publication number
FI893115A0
FI893115A0 FI893115A FI893115A FI893115A0 FI 893115 A0 FI893115 A0 FI 893115A0 FI 893115 A FI893115 A FI 893115A FI 893115 A FI893115 A FI 893115A FI 893115 A0 FI893115 A0 FI 893115A0
Authority
FI
Finland
Prior art keywords
preparation
therapeutically useful
phosphate derivatives
analogous process
mitomycin phosphate
Prior art date
Application number
FI893115A
Other languages
English (en)
Swedish (sv)
Other versions
FI893115A (fi
FI90982C (fi
FI90982B (fi
Inventor
Peter D Senter
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FI893115A0 publication Critical patent/FI893115A0/fi
Publication of FI893115A publication Critical patent/FI893115A/fi
Application granted granted Critical
Publication of FI90982B publication Critical patent/FI90982B/fi
Publication of FI90982C publication Critical patent/FI90982C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI893115A 1988-06-29 1989-06-26 Analogiamenetelmä terapeuttisesti käyttökelpoisten mitomysiinifosfaattijohdannaisten valmistamiseksi FI90982C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21320188 1988-06-29
US07/213,201 US4874779A (en) 1988-06-29 1988-06-29 Mitomycin phosphate derivatives

Publications (4)

Publication Number Publication Date
FI893115A0 true FI893115A0 (fi) 1989-06-26
FI893115A FI893115A (fi) 1989-12-30
FI90982B FI90982B (fi) 1994-01-14
FI90982C FI90982C (fi) 1994-04-25

Family

ID=22794125

Family Applications (1)

Application Number Title Priority Date Filing Date
FI893115A FI90982C (fi) 1988-06-29 1989-06-26 Analogiamenetelmä terapeuttisesti käyttökelpoisten mitomysiinifosfaattijohdannaisten valmistamiseksi

Country Status (31)

Country Link
US (1) US4874779A (fi)
JP (1) JP2742568B2 (fi)
KR (1) KR0145088B1 (fi)
AT (1) AT398203B (fi)
AU (1) AU606288B2 (fi)
BE (1) BE1002655A3 (fi)
CA (1) CA1334671C (fi)
CH (1) CH678728A5 (fi)
CY (1) CY1815A (fi)
DD (1) DD284017A5 (fi)
DE (1) DE3921022B4 (fi)
DK (1) DK168293B1 (fi)
ES (1) ES2016032A6 (fi)
FI (1) FI90982C (fi)
FR (1) FR2633625B1 (fi)
GB (1) GB2220205B (fi)
GR (1) GR1000955B (fi)
HK (1) HK39695A (fi)
HU (1) HU202245B (fi)
IE (1) IE62363B1 (fi)
IL (1) IL90751A (fi)
IT (1) IT1230166B (fi)
LU (1) LU87543A1 (fi)
MY (1) MY104044A (fi)
NL (1) NL194916C (fi)
NO (1) NO176103C (fi)
NZ (1) NZ229650A (fi)
PT (1) PT91004B (fi)
SE (1) SE468770B (fi)
YU (1) YU132689A (fi)
ZA (1) ZA894875B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552154A (en) * 1989-11-06 1996-09-03 The Stehlin Foundation For Cancer Research Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof
US5091523A (en) * 1990-04-25 1992-02-25 Georgetown University Mitomycin derivatives having reduced bone marrow toxicity, processes for their preparation, and the uses thereof
US6080751A (en) * 1992-01-14 2000-06-27 The Stehlin Foundation For Cancer Research Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof
US6098229A (en) * 1998-09-17 2000-08-08 Ward; William Kevin Grill cleaning apparatus
EP1368054B1 (en) * 2001-03-08 2007-10-03 Nymox Pharmaceutical Corporation Using neural thread proteins to treat tumors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1090707A (en) * 1965-11-05 1967-11-15 Kyowa Hakko Kogyo Kk Mitomycin c derivatives
FR2397425A1 (fr) * 1977-07-11 1979-02-09 Rhone Poulenc Ind Nouveaux derives de la daunorubicine, leur preparation et les compositions qui les contiennent
US4642352A (en) * 1983-12-23 1987-02-10 Bristol-Myers Company Acylamino mitosanes
JPS6354380A (ja) * 1986-08-26 1988-03-08 Kyowa Hakko Kogyo Co Ltd マイトマイシン誘導体

Also Published As

Publication number Publication date
FI893115A (fi) 1989-12-30
FR2633625B1 (fr) 1991-11-15
ES2016032A6 (es) 1990-10-01
PT91004B (pt) 1994-11-30
HU202245B (en) 1991-02-28
DK318789A (da) 1989-12-30
ATA155589A (de) 1994-02-15
DE3921022A1 (de) 1990-03-15
BE1002655A3 (fr) 1991-04-23
GB8914848D0 (en) 1989-08-16
IT1230166B (it) 1991-10-14
US4874779A (en) 1989-10-17
ZA894875B (en) 1990-05-30
NL8901623A (nl) 1990-01-16
DD284017A5 (de) 1990-10-31
HUT51638A (en) 1990-05-28
NZ229650A (en) 1991-10-25
GB2220205A (en) 1990-01-04
PT91004A (pt) 1989-12-29
YU132689A (en) 1991-04-30
NO176103B (no) 1994-10-24
GB2220205B (en) 1991-10-16
SE8902340D0 (sv) 1989-06-28
AU606288B2 (en) 1991-01-31
AU3721789A (en) 1990-01-04
IL90751A (en) 1994-01-25
FR2633625A1 (fr) 1990-01-05
NO892688D0 (no) 1989-06-28
NL194916B (nl) 2003-03-03
KR910000738A (ko) 1991-01-30
FI90982C (fi) 1994-04-25
SE468770B (sv) 1993-03-15
CH678728A5 (fi) 1991-10-31
IE62363B1 (en) 1995-01-25
AT398203B (de) 1994-10-25
JP2742568B2 (ja) 1998-04-22
KR0145088B1 (ko) 1998-07-15
GR890100421A (en) 1991-11-15
FI90982B (fi) 1994-01-14
DK168293B1 (da) 1994-03-07
CA1334671C (en) 1995-03-07
NO176103C (no) 1995-02-01
NL194916C (nl) 2003-07-04
JPH0248588A (ja) 1990-02-19
HK39695A (en) 1995-03-31
DE3921022B4 (de) 2004-02-26
GR1000955B (el) 1993-03-16
IE892104L (en) 1989-12-29
CY1815A (en) 1995-10-20
SE8902340L (sv) 1989-12-30
IL90751A0 (en) 1990-01-18
IT8921023A0 (it) 1989-06-28
LU87543A1 (fr) 1990-02-28
MY104044A (en) 1993-10-30
NO892688L (no) 1990-01-02
DK318789D0 (da) 1989-06-27

Similar Documents

Publication Publication Date Title
FI92934B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-deoksinojirimysiinijohdannaisten valmistamiseksi
FI892881A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten aminohappojohdannaisten va lmistamiseksi
FI890282A (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI891538A (fi) Menetelmä farmaseuttisesti käyttökelpoisten fenolisubstituoitujen gem-difosfonaattijohdannaisten valmistamiseksi
FI90346C (fi) Menetelmä terapeuttisesti käyttökelpoisten nor-statiini- ja nor-syklostatiinipolypeptidien valmistamiseksi
FI883064A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
FI892182A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI880869A (fi) Menetelmä terapeuttisesti aktiivisten tetratsolijohdannaisten valmistamiseksi
FI890283A (fi) Menetelmä terapeuttisesti käyttökelpoisten 25-hydroksi-vitamiinin D-johdannaisten valmistamiseksi
FI93215C (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
NO173334C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner
FI884910A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten bentsopyraanijohdannaisten valmistamiseksi
FI892948A (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI104075B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-karboksitienyylikarbamoyylipyrrolidin-4-yylitiokarbapeneemi-3-karboksyylihappojohdannaisten valmistamiseksi
FI893003A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi
FI902727A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI903863A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
NO174422C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
FI903077A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia
FI94351B (fi) Menetelmä terapeuttisesti käyttökelpoisten peptidijohdannaisten valmistamiseksi
FI92188C (fi) Menetelmä terapeuttisesti käyttökelpoisten fenoksialkyylipyrokatekolijohdannaisten valmistamiseksi
FI911701A (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-substituoitujen alkyyli-3-karboksikarbapeneemien valmistamiseksi
FI893115A0 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten mitomysiinifosfaattijohdannaisten valmistamiseksi
NO177673C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive N7-substituerte mitomycinderivater
FI893434A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten sykloalkyylitiatsolijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: ONCOGEN LIMITED PARTNERSHIP